Meghan Rosen is a senior writer who reports on the life sciences for Science News. She earned a Ph.D. in biochemistry and molecular biology with an emphasis in biotechnology from the University of
Seismic data have captured the tense quiet of the COVID-19 lockdowns and the thunderous excitement of Taylor Swift’s Eras Tour. And now, another human experience has been written in seismic signals: the shock
Antibiotic resistance is a fast-growing public health crisis, causing more than a million global deaths annually and contributing to nearly 5 million more. These infections are more difficult and more expensive to treat
For more than 100,000 years, a Greek volcano lay silent. But deep underground, it was still growing. Tiny zircon crystals show magma was quietly brewing between eruptions, researchers report April 22 in Science
The UK’s Advanced Research and Innovation Agency (ARIA) was established in 2023 with the goal of pursuing “high-risk, high-reward” moonshots in sectors ranging from bolstering food security to new ways of ramping up
The rings around Uranus have mystified astronomers for almost half a century. Now, thanks to a combination of ground- and space-based telescopic observations, scientists think they’ve worked out where two of these rings
The latest brain-computer interface could help people recover from severe depression. Motif Neurotech announced Monday that the US Food and Drug Administration has approved a human study to trial the company’s blueberry-sized brain
Filtering a protein out of a pregnant person’s blood may help ease a dangerous complication of pregnancy. In a study of 16 women with early preeclampsia, pulling a particular protein from their blood
War had already darkened Tehran’s skies by March 8. When rain began to fall, residents said it was thick, foul-smelling and dark in color. Some described it as black rain, coating streets, rooftops,
Google DeepMind’s AlphaFold has already revolutionized scientists’ understanding of proteins. Now, the ability of the platform to design safe and effective drugs is about to be put to the test. Isomorphic Labs, the
